Historical Stock Price
ETFs Holding ABAX »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
08/14/2017 $47.00 $47.73 $46.94 $47.01 92.50K
08/15/2017 $47.16 $47.16 $46.31 $46.63 92.10K
08/16/2017 $46.90 $47.85 $46.76 $47.26 83.90K
08/17/2017 $47.07 $48.00 $47.07 $47.74 102.50K
08/18/2017 $47.43 $48.00 $46.50 $46.53 97.80K
Abaxis is engaged in developing, manufacturing and marketing portable blood analysis systems for use in the human or veterinary patient-care to provide clinicians with blood constituent measurements. Co. has two business segments: medical market, with products manufactured and sold in this segment primarily consist of Piccolo chemistry analyzers and medical reagent discs; and veterinary market, with product offerings that include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.
ABAX historical stock prices picture
Abaxis (ABAX) has the following price history information. Looking back at ABAX historical stock prices for the last five trading days, on August 14, 2017, ABAX opened at $47.00, traded as high as $47.73 and as low as $46.94, and closed at $47.01. Trading volume was a total of 92.50K shares. On August 15, 2017, ABAX opened at $47.16, traded as high as $47.16 and as low as $46.31, and closed at $46.63. Trading volume was a total of 92.10K shares. On August 16, 2017, ABAX opened at $46.90, traded as high as $47.85 and as low as $46.76, and closed at $47.26. Trading volume was a total of 83.90K shares. On August 17, 2017, ABAX opened at $47.07, traded as high as $48.00 and as low as $47.07, and closed at $47.74. Trading volume was a total of 102.50K shares. On August 18, 2017, ABAX opened at $47.43, traded as high as $48.00 and as low as $46.50, and closed at $46.53. Trading volume was a total of 97.80K shares.

ABAX Historical Stock Prices By Date:

ABAX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abaxis shares, starting with a $10,000 purchase of ABAX, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 08/21/2007
End date: 08/18/2017
Start price/share: $20.79
End price/share: $46.53
Starting shares: 481.00
Ending shares: 509.13
Dividends reinvested/share: $2.50
Total return: 136.90%
Average Annual Total Return: 9.01%
Starting investment: $10,000.00
Ending investment: $23,695.36
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/21/2007
End date: 08/18/2017
Start price/share: $20.79
End price/share: $46.53
Dividends collected/share: $2.50
Total return: 135.83%
Average Annual Total Return: 8.96%
Starting investment: $10,000.00
Ending investment: $23,586.90
Years: 10.00
Date Close
08/14/2017$47.01
08/15/2017$46.63
08/16/2017$47.26
08/17/2017$47.74
08/18/2017$46.53
ABAX is categorized under the Healthcare sector; below are some other companies in the same sector:

ABBV Historical Stock Prices
ABC Historical Stock Prices
ABEO Historical Stock Prices
ABIO Historical Stock Prices
ABMD Historical Stock Prices
ABT Historical Stock Prices
ABUS Historical Stock Prices
ACAD Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices

ABAX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.